3.1
See NICE's topic page on breast cancer for technology appraisals that NICE has published, including on drugs such as temozolomide, capecitabine, taxanes, trastuzumab and vinorelbine.
Guidance
3 Further information
3.2
Sources of evidence
The evidence considered by the Interventional Procedures Advisory Committee is described in the overview.
Information for patients
NICE has produced information for the public on this procedure. It explains the nature of the procedure and the guidance issued by NICE, and has been written with patient consent in mind.
ISBN: 978-1-4731-6222-8